A case of continuous infusion of milrinone during continuous venovenous hemofiltration causing high plasma concentration of milrinone

Japanese Journal of Anesthesiology

Volumn 54, Issue 2, 2005, Pages 180-182

  Hasei, Mari ^a   Uchiyama, Akinori ^a   Iguchi, Naoya ^a   Fujino, Yuji ^a   Nishimura, Masaji ^a   Taenaka, Nobuyuki ^a   Mashimo, Takashi ^a  

^a OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hemofiltration; Milrinone; Plasma concentration; Renal failure

Indexed keywords

MILRINONE;

AGED; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY FAILURE; MITRAL VALVE REPLACEMENT; POSTOPERATIVE COMPLICATION; SIDE EFFECT;

AGED; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MILRINONE; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PHOSPHODIESTERASE INHIBITORS; POSTOPERATIVE PERIOD;

EID: 14944376625     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Colucci WS, Wright RF, Braunwald E. New positive inotropic agents in the treatment of congestive heart failure, II mechanisms of action and recent clinical developments. N Engl J Med 1986; 314: 349-58.
2. Anderson JL, Baim DS, Fein SA, Goldstein RA, Lejemtel TH, Likoff MJ. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with sever congestive heart failure: A multicenter study. J Am Coll Cardiol 1987; 9; 711-22.
3. Timothy M, Huffman, Gil Wernovsky, Andrew MA, Thomas JK, David PN. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 996-1002.
4. Bailey JM, Miller Be, LU W, Tosone SK, Kanter KR, Tan VK. The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology 1999; 90: 1012-8.
5. Stroshane RM, Koss RF, Biddlecome CE, Luczkowec C, Edelson J. Oral and intravenous pharmacokinetics of milrinone in human volunteers. J Pharm Sci 1984; 73: 1438-41.
6. Holmes JR, Kubo SH, Cody RJ, Kligfield P. Milrinone in congestive heart failure: observations on ambulatory ventricular arrtythmias. Am Heart J 1986; 110: 800-6.
7. Anderson JL, Askins JC, Gilbert EM, Menlove RL, Lutz JR. Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone. Am Heart J 1986; 111: 466-74.
8. Charles C, Canver, Jyotirmay C. Milrinone for long-term pharmacologic support of the status 1 heart transplant candidates. Ann Thorac Surg 2000; 69: 1823-6.
9. Taniguchi T, Shibata K, Saito S, Matumoto H, Okeie K. Pharmacokinetics of milrinone in patients with congestive heart failure during continuous venovenous hemofiltration. Intensive Care Med 2000; 26: 1089-93.
10. Larsson R, Liedholm H, Andersson KE, Keane MA, Henry G. Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impariment. Eur J Clin Pharmacol 1986; 29: 549-53.